Alerts will be sent to your verified email
Verify Email
AKUMS
Positive for this company
Neutral for this company
Negative for this company
Insufficient data to analyse
Akums Drugs and Pharmaceuticals is a pharmaceutical contract development and manufacturing organization (CDMO) offering a comprehensive range of pharmaceutical products and services in India and overseas. As one of the leading CDMOs in India, the company owns the intellectual property for the manufacturing processes of several of its formulations, and its core business is focused on providing end-to-end product development and manufacturing solutions to its clients.
Akums Drugs & Pharma major competitors are Strides Pharma Scien, FDC, Marksans Pharma, Shilpa Medicare, Aarti Pharmalabs, Supriya Lifescience, Suven Life Sciences.
Market Cap of Akums Drugs & Pharma is ₹7,025 Crs.
While the median market cap of its peers are ₹7,445 Crs.
Akums Drugs & Pharma seems to be less financially stable compared to its competitors.
Altman Z score of Akums Drugs & Pharma is 7.68 and is ranked 4 out of its 8 competitors.
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Annual Report | FY25 | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY11 | FY10 | ||
| Earnings Release | May Aug | Jun Sep Dec | ||||||||||||||||
| Investor Presentation | May Aug | Jun Sep Dec | ||||||||||||||||
| Conference Call | Mar Jun | Sep Dec | ||||||||||||||||
|
Conference Call SummaryCon Call Summary
Powered by Gemini
|
